BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25906118)

  • 1. CD123 Immunohistochemical Expression Is a Specific But Insensitive Marker of Early T-precursor Leukemia.
    Hellman C; Marcogliese AN; Djokic M; Roth CG
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):e4-5. PubMed ID: 25906118
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
    Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
    Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.
    Du W; Li J; Liu W; He Y; Yao J; Liu Y; Lin J; Zheng J
    Tumour Biol; 2016 Mar; 37(3):3817-21. PubMed ID: 26474588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
    Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
    Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.
    Bras AE; de Haas V; van Stigt A; Jongen-Lavrencic M; Beverloo HB; Te Marvelde JG; Zwaan CM; van Dongen JJM; Leusen JHW; van der Velden VHJ
    Cytometry B Clin Cytom; 2019 Mar; 96(2):134-142. PubMed ID: 30450744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult T-cell leukemia/lymphoma with an unusual CD1a positive phenotype.
    Juncà J; Botín T; Vila J; Navarro JT; Millá F
    Cytometry B Clin Cytom; 2014 Jul; 86(4):292-6. PubMed ID: 24115371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
    Jain N; Lamb AV; O'Brien S; Ravandi F; Konopleva M; Jabbour E; Zuo Z; Jorgensen J; Lin P; Pierce S; Thomas D; Rytting M; Borthakur G; Kadia T; Cortes J; Kantarjian HM; Khoury JD
    Blood; 2016 Apr; 127(15):1863-9. PubMed ID: 26747249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations.
    Rollins-Raval M; Pillai R; Warita K; Mitsuhashi-Warita T; Mehta R; Boyiadzis M; Djokic M; Kant JA; Roth CG
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):212-7. PubMed ID: 22914610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract.
    Yang F; Liu T; Zhao H; Hu Z; Xiao L; Liu Y; Wang X; Li Z
    Int J Clin Exp Pathol; 2014; 7(9):6350-6. PubMed ID: 25337290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.
    Balbach ST; Makarova O; Bonn BR; Zimmermann M; Rohde M; Oschlies I; Klapper W; Rössig C; Burkhardt B
    Leukemia; 2016 Apr; 30(4):970-3. PubMed ID: 26216196
    [No Abstract]   [Full Text] [Related]  

  • 13. Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
    Xi Y; Li J; Zhang P; Bai W; Gao N; Bai W; Zhang Y; Wu Y; Ning Y
    Exp Mol Pathol; 2015 Oct; 99(2):297-302. PubMed ID: 26231295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic CD3 Positivity as the Only Clue for the Diagnosis of T-Acute Lymphoblastic Leukemia With Cutaneous Deposits: A Case Report.
    Elbendary A; Abdelkader HA; Abdel-Galeil Y; El-Mofty M; Sultan AM; Elkomi AS; Abdel-Halim MRE
    Am J Dermatopathol; 2020 Jan; 42(1):43-45. PubMed ID: 31124883
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological characteristics of T-lineage acute lymphoblastic leukemia in 23 children].
    Xiong H; Zhang YD; Hu Q; Sun Y; Liu SY; Zhang LQ; Liu AG; Wang GL
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):605-8. PubMed ID: 20704789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia.
    Xi Y; Li J; Zan L; Wang J; Wang G; Ning Y
    Hum Pathol; 2013 Jun; 44(6):1011-6. PubMed ID: 23260326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog pathway mutations in T-cell acute lymphoblastic leukemia.
    Dagklis A; Pauwels D; Lahortiga I; Geerdens E; Bittoun E; Cauwelier B; Tousseyn T; Uyttebroeck A; Maertens J; Verhoef G; Vandenberghe P; Cools J
    Haematologica; 2015 Mar; 100(3):e102-5. PubMed ID: 25527561
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma.
    Fromm JR
    Cytometry B Clin Cytom; 2011 Mar; 80(2):91-9. PubMed ID: 20809502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
    Khurana S; Heckman MG; Craig FE; Cochuyt JJ; Greipp P; Rahman ZA; Sproat LZ; Litzow M; Foran JM; Jiang LJ
    Arch Pathol Lab Med; 2024 Apr; 148(4):471-475. PubMed ID: 37522711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
    Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA
    Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.